Rapid Micro Biosystems (RPID) Capital Expenditures (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Capital Expenditures of $13000.0 for Q1 2026, down 95.92% on a YoY basis from $319000.0 in Q1 2025, and up 101.74% sequentially from -$746000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Capital Expenditures (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Capital Expenditures data on file, last reported at $13000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 95.92% year-over-year to $13000.0; the trailing twelve-month figure through Mar 2026 stood at -$294000.0 (down 126.75% YoY), and the FY2025 full-year result was $12000.0, down 99.12% from the prior year.
- Capital Expenditures advanced to $13000.0 in Q1 2026, from -$746000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $5.5 million in Q3 2022 to a low of -$6.1 million in Q4 2022.
- A 5-year average of $70941.2 and a median of $13000.0 in 2026 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures slumped 1299.29% in 2022 and jumped 2255.17% in 2025, its largest moves.
- Tracing RPID's Capital Expenditures over 5 years: stood at -$6.1 million in 2022, then soared by 96.58% to -$209000.0 in 2023, then surged by 739.71% to $1.3 million in 2024, then slumped by 155.8% to -$746000.0 in 2025, then soared by 101.74% to $13000.0 in 2026.
- Business Quant data shows RPID's Capital Expenditures at $13000.0 in Q1 2026, -$746000.0 in Q4 2025, and $683000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | -746,000.00 |
| Dec 31, 2025 | -746,000.00 |
| Sep 30, 2025 | 683,000.00 |
| Sep 30, 2025 | 683,000.00 |
| Jun 30, 2025 | -244,000.00 |
| Jun 30, 2025 | -244,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Mar 31, 2025 | 319,000.00 |
| Dec 31, 2024 | 1.34 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | -586,000.00 |
| Jun 30, 2024 | -586,000.00 |
| Mar 31, 2024 | 585,000.00 |
| Mar 31, 2024 | 585,000.00 |
| Dec 31, 2023 | -209,000.00 |
| Dec 31, 2023 | -209,000.00 |